Researchers from Josep Carreras Leukemia Research Institute Detail New Studies and Findings in the Area of Pluripotent Stem Cells (A novel human pluripotent stem cell gene activation system identifies IGFBP2 as a mediator in the production of...).

Publikováno v: Stem Cell Week; 1/9/2025, p125-125, 1p

Genetics and epigenetics of leukemia and lymphoma : from knowledge to applications, meeting report of the Josep Carreras Leukaemia Research Institute

Autor: Parra, Maribel, Baptista, Maria Joao, Genescà, Eulàlia, Llinàs-Arias, Pere, Esteller, M., Universitat Autònoma de Barcelona

Publikováno v: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Hematological Oncology
Recercat. Dipósit de la Recerca de Catalunya
instname
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)

The meeting, which brought together leading scientists and clinicians in the field of leukemia and lymphoma, was held at the new headquarters of the Josep Carreras Leukaemia Research Institute (IJC) in Badalona, Catalonia, Spain, September 19‐20, 2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef246840546e5d0d9f7e786f85323df3
https://ddd.uab.cat/record/236306

Study Results from Josep Carreras Leukaemia Research Institute in the Area of Chromatin Published (A complex interplay between H2A.Z and HP1 isoforms regulates pericentric heterochromatin).

Publikováno v: Genomics & Genetics Weekly; 12/01/2023, p2055-2055, 1p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Researchers from the Hospital 12 de Octubre and the Josep Carreras Institute create a cell therapy based on STAb cells for a type of leukemia with few treatment options.

Publikováno v: Immunotherapy Weekly; 1/31/2023, p726-726, 1p